Integer Holdings Corporation (NYSE:ITGR) Stock Position Raised by Laurus Global Equity Management Inc.

Laurus Global Equity Management Inc. lifted its stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 16.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,770 shares of the medical equipment provider's stock after buying an additional 6,855 shares during the period. Integer comprises approximately 3.8% of Laurus Global Equity Management Inc.'s holdings, making the stock its 9th largest holding. Laurus Global Equity Management Inc. owned approximately 0.14% of Integer worth $5,637,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ITGR. Lee Danner & Bass Inc. acquired a new stake in shares of Integer in the 4th quarter valued at about $27,000. Opal Wealth Advisors LLC acquired a new stake in Integer during the first quarter worth approximately $28,000. AdvisorNet Financial Inc acquired a new stake in Integer during the first quarter worth approximately $28,000. Bessemer Group Inc. grew its position in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its stake in Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Trading Down 1.7%

Shares of ITGR stock traded down $2.02 during mid-day trading on Tuesday, hitting $117.45. The company's stock had a trading volume of 409,538 shares, compared to its average volume of 388,768. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. The company's fifty day simple moving average is $119.91 and its 200-day simple moving average is $124.82. The company has a market cap of $4.10 billion, a PE ratio of 55.66, a P/E/G ratio of 1.03 and a beta of 0.98. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The company's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 EPS. As a group, equities research analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ITGR shares. Truist Financial set a $150.00 price target on shares of Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Raymond James Financial raised their target price on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Benchmark lowered their target price on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Finally, KeyCorp lowered their target price on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $145.00.

Insider Transactions at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer owned 47,000 shares in the company, valued at $5,788,990. The trade was a 87.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the completion of the transaction, the director owned 22,170 shares in the company, valued at $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock worth $44,577,115 in the last 90 days. Insiders own 2.16% of the company's stock.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.